Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Other financing activities (2017 - 2025)

Historic Other financing activities for BioRestorative Therapies (BRTX) over the last 7 years, with Q3 2025 value amounting to $69066.0.

  • BioRestorative Therapies' Other financing activities changed N/A to $69066.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $69066.0, marking a year-over-year change of. This contributed to the annual value of $148697.0 for FY2024, which is 188262.67% up from last year.
  • Latest data reveals that BioRestorative Therapies reported Other financing activities of $69066.0 as of Q3 2025.
  • BioRestorative Therapies' 5-year Other financing activities high stood at $148697.0 for Q4 2024, and its period low was $33608.0 during Q1 2025.
  • In the last 3 years, BioRestorative Therapies' Other financing activities had a median value of $58785.0 in 2022 and averaged $68648.5.